Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ELLEN A NEYLON

Physician Assistants & Advanced Practice Nursing Providers Clinical Nurse Specialist Oncology

NPI
1174894554
CMS profile
11137607
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$20,622.47

122 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ELLEN A NEYLON

NPI 1174894554 · CMS profile ID 11137607

Physician Assistants & Advanced Practice Nursing Providers / Clinical Nurse Specialist / Oncology

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174894554?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ELLEN A NEYLON, NPI 1174894554, CMS profile ID 11137607. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174894554?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ELLEN A NEYLON, NPI 1174894554, CMS profile ID 11137607. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174894554?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ELLEN A NEYLON, NPI 1174894554, CMS profile ID 11137607, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1174894554?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

122 matching records · $20,622.47 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 122 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 122.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $183.4107/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899061113 CMS
Novo Nordisk Inc $2,137.5007/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899201017 CMS
Novo Nordisk Inc $113.6307/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899479729 CMS
Novo Nordisk Inc $352.0607/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899479731 CMS
Amryt Pharma Holdings Ltd $22.0807/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881046555 CMS
Abbott Laboratories $16.9707/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920079377 CMS
Bayer HealthCare Pharmaceuticals Inc. $41.6407/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930515237 CMS
Novo Nordisk Inc $12.2007/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898702327 CMS
Dexcom, Inc. $18.6007/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957372815 CMS
Corcept Therapeutics $13.8407/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948784483 CMS
SANOFI-AVENTIS U.S. LLC $15.0506/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939047113 CMS
Bayer HealthCare Pharmaceuticals Inc. $19.7606/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930380787 CMS
Horizon Therapeutics plc $19.4806/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937735517 CMS
Novo Nordisk Inc $13.3406/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898981225 CMS
Lilly USA, LLC $23.1706/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918561501 CMS
Bayer HealthCare Pharmaceuticals Inc. $83.3306/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930556611 CMS
Novo Nordisk Inc $106.8006/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898623837 CMS
Novo Nordisk Inc $950.0006/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899479735 CMS
Novo Nordisk Inc $21.8706/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899460217 CMS
Abbott Laboratories $22.2806/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920616605 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.9806/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887784849 CMS
Amryt Pharma Holdings Ltd $144.0906/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881046587 CMS
Dexcom, Inc. $16.3805/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957372817 CMS
Abbott Laboratories $8.2605/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920616587 CMS
Biohaven Pharmaceutical Holding Company Ltd. $124.4905/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923903215 CMS
Lilly USA, LLC $27.2905/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918499267 CMS
Horizon Therapeutics plc $15.5505/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937735515 CMS
Abbott Laboratories $15.2505/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920616593 CMS
Novo Nordisk Inc $51.3605/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899491019 CMS
Novo Nordisk Inc $22.1705/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899556685 CMS
Corcept Therapeutics $19.2605/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 948784445 CMS
Lilly USA, LLC $105.9105/05/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918499269 CMS
Novo Nordisk Inc $22.2305/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899026591 CMS
Novo Nordisk Inc $120.0605/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899103941 CMS
Novo Nordisk Inc $1,235.0005/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899156107 CMS
Xeris Pharmaceuticals, Inc. $17.7505/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946507591 CMS
ABBVIE INC. $17.2804/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893859985 CMS
Lilly USA, LLC $29.3404/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918487519 CMS
Amryt Pharma Holdings Ltd $27.8304/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 881046521 CMS
Abbott Laboratories $8.2304/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920079373 CMS
Lilly USA, LLC $102.0204/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918534137 CMS
Novo Nordisk Inc $22.9704/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899026599 CMS
Novo Nordisk Inc $340.7904/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 898623845 CMS
Novo Nordisk Inc $805.0104/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899103957 CMS
Novo Nordisk Inc $170.4004/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899156215 CMS
Novo Nordisk Inc $262.0104/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899597581 CMS
Novo Nordisk Inc $2,816.7504/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899597587 CMS
Abbott Laboratories $19.2503/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921865387 CMS
Eli Lilly and Company $124.4803/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918487521 CMS
Amneal Pharmaceuticals LLC $12.7003/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956624253 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $17,163.14 98
PY2022 $20,622.47 122
PY2023 $47,947.98 239
PY2024 $32,086.49 185
PY2025 $20,593.02 143

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Recipient $1,439.69 19
PY2023 Recipient $1,837.01 11
PY2022 Recipient $2,645.48 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient ABBVIE INC. $156.53 04/13/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100683001
Recipient ABBVIE INC. $50.54 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682989
Recipient ABBVIE INC. $37.50 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682991
Recipient ABBVIE INC. $69.00 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682993
Recipient ABBVIE INC. $12.73 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682995
Recipient ABBVIE INC. $7.17 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682997
Recipient ABBVIE INC. $32.70 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682999
Recipient ABBVIE INC. $226.86 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682977
Recipient ABBVIE INC. $37.50 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682979
Recipient ABBVIE INC. $70.25 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682981
Recipient ABBVIE INC. $50.54 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682983
Recipient ABBVIE INC. $25.00 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682985
Recipient ABBVIE INC. $125.05 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682987
Recipient ABBVIE INC. $176.86 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682965
Recipient ABBVIE INC. $37.10 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682967
Recipient ABBVIE INC. $259.98 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682969
Recipient ABBVIE INC. $21.80 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682971
Recipient ABBVIE INC. $17.64 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682973
Recipient ABBVIE INC. $24.94 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682975